Sudden Increases in U.S. Stimulant Prescribing: Alarming or Not?

Abstract

Get full access to this article

View all access options for this article.

References

Danielson

M. L.

Bohm

M. K.

Newsome

Claussen

A. H.

Kaminski

J. W.

Grosse

S. D.

Siwakoti

Arifkhanova

Bitsko

R. H.

Robinson

L. R.

(2023). Trends in prescription stimulant fills among commercially insured children and adults — United States, 2016–2021. Morbidity and Mortality Weekly Report.

Faraone

S. V.

Banaschewski

Coghill

Zheng

Biederman

Bellgrove

M. A.

Newcorn

J. H.

Gignac

Al Saud

N. M.

Manor

Rohde

L. A.

Yang

Cortese

Almagor

Stein

M. A.

Albatti

T. H.

Aljoudi

H. F.

Alqahtani

M. M. J.

Asherson

. . . Wang

(2021). The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neuroscience & Biobehavioral Reviews, 128, 789–818.

Song

Zha

Yang

Zhang

Rudan

(2021). The prevalence of adult attention-deficit hyperactivity disorder: A global systematic review and meta-analysis. Journal of Global Health, 11, 04009.

Willcutt

E. G.

(2012). The prevalence of DSM-IV attention-deficit/hyperactivity disorder: A meta-analytic review. Neurotherapeutics, 9(3), 490–499.

Yeung

Abi-Jaoude

(2022). TikTok and attention-deficit/hyperactivity disorder: A cross-sectional study of social media content quality. The Canadian Journal of Psychiatry, 67(12), 899–906.